-
PsyBio Therapeutics Presents "How Genetically Modified Bacteria Can Yield Best-In-Class Psychedelics" At The Psychedelic Capital Conference
Friday, April 29, 2022 - 12:14pm | 160Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Evan Levine, CEO and Chairman of PsyBio Therapeutics Corp (TSXV: PSYB) (OTCQB: PSYBF), was a guest speaker at Benzinga’s Psychedelic Capital Conference (...
-
Meet PsyBio, A Company Producing Psilocybin From Genetically-Modified Bacteria
Friday, May 28, 2021 - 9:53am | 1150Read More...As psychedelics draw closer to legalization, companies in the industry have yet to figure out the most efficient and cost-effective way of producing psilocybin and other molecules on a commercial scale. To date, the industry has not reached a consensus as to the most effective production method to...
-
'Psyched': New Leaf Brands Changes Name To Mydecine, Numinus Debuts On TSXV, MindMed To Research MDMA-LSD Interactions
Saturday, June 6, 2020 - 3:15pm | 1484Read More...Psyched is a bi-monthly column covering the most important developments in the industry of medicinal psychedelics. We hope you follow us periodically as we report on the growth of this exciting new industry. New Leaf Brands Changes Name To Mydecine, Announces New HQ Cannabis company NewLeaf...
